Joint Commission Accreditation Survey
UroCor LabsSM can help predict cancer recurrence and progression with its p53 proprietary analysis.
p53 negative 2%-8% progress in 2 years
p53 positive 40%-60% progress in 2 years
A novel genetic test run off a urine sample helps predict recurrence and progression independent of tumor stage and grade.
Powerfully predicts recurrence
Powerfully predicts survival
Establish p53 status before treatment Helps identify patients who need to be closely monitored
Clinical monitoring schedulep53 status year 1, year 2, year 3, year 4, year 5
Clinical Journal Abstracts
Click here to learn more about the p53 test by exploring clinical journal abstracts from accredited sources.
p53 Prognostic Assay Physician Report
Click here to view a p53 Prognostic Assay Physician Report exclusive only to UroCor LabsSM.
p53 Prognostic Assay Patient Education Report
Click here to view a p53 Prognostic Assay Patient Education Report exclusive only to UroCor LabsSM.
Patient Support Services for Bladder Prognostics
Click here to learn more about UroCor LabsSM PSS for Bladder Prognostics at-home testing that allows specimen acquisition in the convenience of your patient’s home.
More Info/Rep Visit
